Article info
Osteoarthritis
Targeting FoxO transcription factors with HDAC inhibitors for the treatment of osteoarthritis
- Correspondence to Professor Martin K Lotz, Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California 92037, USA; mlotz{at}scripps.edu
Citation
Targeting FoxO transcription factors with HDAC inhibitors for the treatment of osteoarthritis
Publication history
- Received July 29, 2021
- Accepted August 27, 2022
- First published September 15, 2022.
Online issue publication
January 23, 2023
Article Versions
- Previous version (15 September 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.